# Study on the Antidepressant Effects and Mechanism of Action of Cang-ai Volatile Oil Based on Near-Infrared Functional Brain Imaging and the NT-Trk Signalling Pathway

> **NCT07384312** · NA · COMPLETED · sponsor: **Dongdong Qin** · enrollment: 60 (actual)

## Conditions studied

- Depression Disorder

## Interventions

- **DRUG:** Cang-ai Volatile Oil
- **DRUG:** Bergamot Essential Oil

## Key facts

- **NCT ID:** NCT07384312
- **Lead sponsor:** Dongdong Qin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07384312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07384312, "Study on the Antidepressant Effects and Mechanism of Action of Cang-ai Volatile Oil Based on Near-Infrared Functional Brain Imaging and the NT-Trk Signalling Pathway". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT07384312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*